Beam Therapeutics
在场
高管
查看带有其 33 名主要高管的组织结构图
Beam Therapeutics 搜索最多的简介
- John Evans, Chief Executive Officer and Board Member
- Mark Fishman, Director
- John Maraganore, Director
高管在Beam Therapeutics变化
- Terry-Ann Burrell, Chief Financial Officer, 将于 20248月1 退休 (新闻发布的2024七月15号).
创建提醒
跟踪 Beam Therapeutics 的高管变动
生物技术
Beam Therapeutics 拥有 2,328 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Inbrain Neuroelectronics 刚刚宣布为 50 筹款数百万美元。 (公布2024十一月23号).
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
生物技术 行业的其他推荐联系人
消息
Beam Therapeutics 的最新新闻稿
- Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference | Beam Therapeutics
- Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results | Beam Therapeutics
- Press Releases | Beam Therapeutics
- Press Releases | Beam Therapeutics
- Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease | Beam Therapeutics
- Beam Therapeutics Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 to Correct a Glycogen Storage Disease Type I Deficiency Disease-Causing Mutation at ESGCT | Beam Therapeutics
- Meet the 2019 STAT Wunderkinds
- Press Releases | Beam Therapeutics
- View more press releases Close
通过电子邮件
